| 1. Chan MM, Fong
D, Soprano KJ, Holmes WF, Heverling H. Inhibition of growth and sensiti-
zation to cisplatin-mediated killing of ovarian cancer cells by polyphenolic
chemopreventive agents. J Cell Physiol. 2003 Jan;194(1):63-70.
2. Navis I, Sriganth P, Premalatha B. Dietary curcumin with cisplatin
administration modu- lates tumor marker indices in experimental
fibrosarcoma. Pharmacological Research. 1999 Mar;39(3):175-79.
3. Ichiki K, Mitani N, Doki Y, Hara H, Misaki T, Saiki I. Regulation
of activator protein-1 activity in the mediastinal lymph node metas-
tasis of lung cancer. Clin Exp Metastasis. 2000;18(7):539-45.
4. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane)
down-regu- lates the constitutive activation of nuclear fac- tor-kappa
B and IkappaBalpha kinase in human multiple myeloma cells, leading
to suppression of proliferation and induction of apoptosis. Blood.
2003 Feb;101(3):1053-62.
5. Lin JK, Chen YC, Huang YT, Lin-Shiau SY. Suppression of protein
kinase C and nuclear oncogene expression as possible molecular mechanisms
of cancer chemoprevention by apigenin and curcumin. J Cell Biochem
Suppl. 1997;28-29:39-48.
6. Cheng AL, Hsu Ch, Lin JK, et al. Phase I clini- cal trial of
curcumin, a chemopreventive agent, in patients with high-risk or pre-malig-
nant lesions. Anticancer Res. Jul-Aug 2001;21(4B):2895-2900.
7. Miyoshi N, Nakamura Y, Ueda Y, et al. Dietary ginger constituents,
galanals A and B, are potent apoptosis inducers in Human T lymphoma
Jurkat cells. Cancer Lett. 2003 Sep 25;199(2):113-9.
8. Chan WH, Wu CC, Yu JS. Curcumin inhibits UV-induced oxidative
stress and apoptotic biochemical changes in human epidermoid carcinoma
A431 cells. J Cell Biochem. Oct 2003;90(2):327-38.
9. Menon LG, Kuttan R, Kuttan G. Antimeta- static activity of curcumin
and catechin. Cancer Lett 1999 Jul 1;141(1-2):159-65.
10. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin:
preclinical and clinical studies. Anticancer Res. Jan-Feb 2003;23(1A):363-98.
11. Ikezaki S, Nishikawa A, Furukawa F, et al. Chemopreventive effects
of curcumin on glandular stomach carcinogenesis induced by N-methyl-N-nitro-N-nitrosoguanidine
and sodium chloride in rats. Anticancer Res. 2001 Sep-Oct;21(5):3407-11.
12. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic potential
of curcumin in human prostate cancer. III. Curcumin inhibits proliferation,
induces apoptosis, and inhibits angiogenesis of LNCaP prostate can-
cer cells in vivo. Prostate. 2001 Jun 1;47(4):293-303.
13. Nakamura K, Yasunaga Y, Segawa T, et al. Curcumin down-regulates
AR gene expres- sion and activation in prostate cancer cell lines.
Int J Oncol. 2002 Oct;21(4):825-30.
14. Hour TC, Chen J, Huang CY, Guan JY, Lu SH, Pu YS. Curcumin enhances
cytotoxicity of chemotherapeutic agents in prostate can- cer cells
by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing
NF- kappaB activation. Prostate. 2002 May 15;51(3):211-8.
15. Gururaj AE, Belakavadi M, Venkatesh DA, Marme D, Salimath BP.
Molecular mecha- nisms of anti-angiogenic effect of curcumin. Biochem
Biophys Res Commun. 2002 Oct 4;297(4):934-42.
16. Cheng PY, Wang M, Morgan ET. Rapid transcriptional suppression
of rat Cyto- chrome P450 genes by endotoxin treatment and its inhibition
by curcumin. J Pharmacol Exp Ther. 2003 Oct 13 [Epub ahead of print].
17. Ray SN, Chattopadhyay N, Mitra A, Siddiqi M, Chatterjee A. Curcumin
exhibits anti- metastatic properties by modulating inte- grin receptors,
collagenase activity, and expression of Nm23 and E-cadherin. J Environ
Pathol Toxicol Oncol. 2003;22(1):49-58.
18. Reddy BS, Rao CV. Novel approaches for colon cancer prevention
by cyclooxygenase-2 inhibitors. J Environ Pathol Toxicol Oncol 2002;21(2):155-64.
19. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski
RZ. Dietary curcumin inhibits chemotherapy-induced apoptosis in models
of human breast cancer. Cancer Res. 2002 Jul 1;62(13):3868-75.
20. Imaida K, Tamano S, Kato K, et al. Lack of chemopreventive effects
of lycopene and curcumin on experimental rat prostate car cinogenesis.
Carcinogenesis. 2001 Mar;22(3):467-72.
21. Satoskar RR, Shah SJ, Shenoy SG. Evalua- tion of anti-inflammatory
property of cur- cumin in patients with postoperative inflam mation.
Int J Clin Pharmacol Ther Toxicol 1986 Dec;24(12):651-4.
22. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B. Treatment
of osteoarthritis with a herbomineral formulation: a double- blind,
placebo-controlled, cross-over study. J Ethnopharmacol. 1991 May-Jun;33(1-2):91-5.
23. Arora RB, Basu N, Kapoor V, Jain AP. Anti-inflammatory studies
on Curcuma- longa (turmeric). Ind J Med Res 1971 Aug;59(8):1289-95.
24. Deodhar SD, Sethi R, Srimal RC. Preliminary studies on antirheumatic
activity of curcumin (diferuloyl methane). Ind J Med Res. 1980 Apr;71:632-4.
25. Chan MM, Ho CT, Huang HI. Effects of three dietary phytochemicals
from tea, rose- mary and turmeric on inflammation-induced nitrate
production. Cancer Lett. 1995 Sep 4;96(1):23-9.
26. Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and
anti-inflamma- tory activities of curcumins I-III from Curcumalonga.
Phytomedicine. Jul 2000;7(4):303-8.
27. Mesa MD, Aguilera CM, Ramirez-Tortosa CL, et al. Oral administration
of a turmeric extract inhibits erythrocyte and liver micro- some membrane
oxidation in rabbits fed with an atherogenic diet. Nutrition. Sep
2003;19(9):800-04.
28. Quiles JL, Aguilera C, Mesa MD, Ramirez- Tortosa MC, Baro L,
Gil A. An ethanolic- aqueous extract of Curcuma longa decreases the
susceptibility of liver microsomes and mitochondria to lipid peroxidation
in atherosclerotic rabbits. Biofactors. 1998;8(1- 2):51-7.
29. Dikshit M, Rastogi L, Shukla R, Srimal RC. Prevention of ischaemia-induced
biochemical changes by curcumin & quinidine in the cat heart.
Indian J Med Res. Jan 1995;101:31-5.
30. Ramirez-Tortosa MC, Mesa MD, Aguilera MC, et al. Oral administration
of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic
effects in rabbits with experimental atherosclerosis. Atherosclerosis.
Dec 1999;147(2):371-8.
31. Quiles JL, Mesa MD, Ramirez-Tortosa CL, et al. Curcuma longa
extract supplementa- tion reduces oxidative stress and attenuates
aortic fatty acid streak development in rab- bits. Arterioscler Thromb
Vasc Biol. Jul 2002 Jul 1;22(7):1225-31.
32. Suryanarayana P, Krishnaswamy K, Reddy GB. Effects of curcumin
on galactose-induced cataractogenesis in rats. Mol Vis. 2003 Jun 9;9:223-30.
33. Galvano F, Piva A, Ritieni A, Galvano G. Dietary strategies
to counteract the effects of mycotoxins: a review. J Food Prot. Jan
2001;64(1)120-31.
34. Koide T, Nose M, Ogihara Y, Yabu Y, Ohta N. Leishmanicidal effects
of curcumin in vitro. Biol Pharm Bull. 2002 Jan;25(1):131-3.
35. Saleheen D, Ali SA, Ashfaq K, Siddiqui AA, Agha A, Yasinzai
MM. Latent activity of cur- cumin against leishmaniasis in vitro.
Biol Pharm Bull. 2002 Mar;25(3):386-9.
36. Shishu, Singla AK, Kaur IP. Inhibitory effect of curcumin and
its natural analogues on geneto toxicity of heterocyclic amines from
cooked food. Indian J Exp Biol. Dec 2002 Dec;40(12):1365-72.
37. Phan TT, See P, Lee ST, Chan SY. Protective effects of curcumin
against oxidative damage on skin cells in vitro: its implication for
wound healing. J Trauma. 2001 Nov;51(5):927-31.
38. Natarajan C, Bright JJ. Curcumin inhibits experimental allergic
encephalomyelitis by blocking signaling through janus kinase- STAT
pathway in T lymphocytes IL-12. J Immunol. 2002;168(12):6506-13.
39. Arun N, Nalini N. Efficacy of turmeric on blood sugar and polyol
pathway in diabetic albino rats. Plant Foods Hum Nutr. 2002;57(1):41-52.
40. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry
spice curcumin reduces oxidative damage and amyloid pathology in an
Alzheimer transgenic mouse. J Neurosci. 2001 Nov 1;21(21):8370-7.
41. Kim DS, Park SY, Kim JK. Curcuminoids from Curcuma longa L.
(Zingiberaceae) that protect PC12 rat pheochromocytoma and normal
human umbilical vein endothe- lial cells from beta(1-42) insult. Neurosci
Lett. Apr 2001;303(1):57-61.
42. Lal B, Kapoor AK, Asthana OP, et al.
Efficacy of curcumin in the management of chronic anterior uveitis.
Phytotherapy Res 1999;13:318–22.
43. White EL, Ross LJ, Schmid SM, Kelloff GJ, Stelle VE, Hill DL.
Screening of potential cancer preventing chemicals for induction of
glutathionine in rat liver cells. Oncol Rep. 1998 Mar-Apr;5(2):507-12.
44. Inano H, Makota O. Prevention of radia tion-induced mammary
tumors. Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):212-23.
45. Inano H, Onoda M. Radioprotective action of curcumin extracted
from Curcuma longa LINN: inhibitory effect on formation of uri- nary
8-hydroxy-2’-deoxyguanosine, tumoro genesis, but not mortality,
induced by gamma-ray irradiation. Int J Radiat Oncol Biol Phys. 2002
Jul 1;53(3):735-43.
46. Ghoneim AI, Abdel-Naim AB, Khalifa AE, El-Denshary ES. Protective
effects of cur cumin against ischaemis-reperfusion insult in rat forebrain.
Pharmacol Res. Sep 2002;46(3):273-9.
47. Sreejayan, Rao MN. Curcuminoids as potent inhibitors of lipid
peroxidation. J Indian Physiol Pharmacol. Dec 1994;46(12):1013-6.
48. Soni KB, Kuttan R. Effects of curcumin administration on serum
peroxides and cholesterol levels in human volunteers. Indian J Physiol
Pharmacol. Oct 1992;36(4):273-5.
49. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS.
Influence of piper- ine on the pharmacokinetics of curcumin in animals
and human volunteers. Planta Med. 1998 May;64(4):353-6.
50. Jayaraman KS. US patent office withdraws patent on Indian herb.
Nature. 1997 Sep 4;389(6646):6. |